Mannkind (MNKD) Retained Earnings (2010 - 2026)
Mannkind (MNKD) reported Retained Earnings of -$3.2 billion for Q1 2026, down 0.75% year-over-year from -$3.2 billion in Q1 2025, and down 0.52% on a QoQ basis from -$3.2 billion in Q4 2025.
Mannkind (MNKD) has 17 years of Retained Earnings data on file, last reported at -$3.2 billion in Q1 2026.
- Quarterly Retained Earnings fell 0.75% year-over-year to -$3.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.2 billion (down 0.75% YoY) and the FY2025 annual result came in at -$3.2 billion, changed 0.18% from the prior year.
- Retained Earnings eased to -$3.2 billion in Q1 2026 per MNKD's latest filing, from -$3.2 billion in the prior quarter.
- Across five years, Retained Earnings topped out at $588000.0 in Q3 2024 and bottomed at -$3.2 billion in Q4 2023.
- The 5-year median for Retained Earnings is -$3.2 billion (2025), against an average of -$2.5 billion.
- The widest annual swing landed in 2023, when Retained Earnings soared 100.01%; it then plunged 727140.86% in 2024.
- Tracing MNKD's Retained Earnings over 5 years: stood at -$3.2 billion in 2022, then slipped by 0.37% to -$3.2 billion in 2023, then climbed by 0.85% to -$3.2 billion in 2024, then gained by 0.18% to -$3.2 billion in 2025, then decreased by 0.52% to -$3.2 billion in 2026.
- Per Business Quant, the three latest MNKD Retained Earnings figures stand at -$3.2 billion (Q1 2026), -$3.2 billion (Q4 2025), and -$3.2 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 130.89 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 36.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -24.89 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | -3.21 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.21 Bn |
| Dec 31, 2025 | -3.20 Bn |
| Sep 30, 2025 | -3.18 Bn |
| Jun 30, 2025 | -3.19 Bn |
| Mar 31, 2025 | -3.19 Bn |
| Dec 31, 2024 | -3.20 Bn |
| Sep 30, 2024 | 588,000.00 |
| Jun 30, 2024 | -3.22 Bn |
| Mar 31, 2024 | -3.22 Bn |
| Dec 31, 2023 | -3.23 Bn |
| Sep 30, 2023 | 443,000.00 |
| Jun 30, 2023 | 443,000.00 |
| Mar 31, 2023 | -3.23 Bn |
| Dec 31, 2022 | -3.22 Bn |
| Sep 30, 2022 | -3.20 Bn |
| Jun 30, 2022 | -3.19 Bn |
| Mar 31, 2022 | -1.08 Mn |
| Dec 31, 2021 | -3.13 Bn |
| Sep 30, 2021 | -3.10 Bn |
| Jun 30, 2021 | -3.10 Bn |
| Mar 31, 2021 | -3.06 Bn |
| Dec 31, 2020 | -3.05 Bn |
| Sep 30, 2020 | -3.02 Bn |
| Jun 30, 2020 | -3.00 Bn |
| Mar 31, 2020 | -3.00 Bn |
| Dec 31, 2019 | -19,000.00 |
| Sep 30, 2019 | -2.98 Bn |
| Jun 30, 2019 | -19,000.00 |
| Mar 31, 2019 | -19,000.00 |
| Dec 31, 2018 | -19,000.00 |
| Sep 30, 2018 | -2.93 Bn |
| Jun 30, 2018 | -18,000.00 |
| Mar 31, 2018 | -15,000.00 |
| Dec 31, 2017 | -2.85 Bn |
| Sep 30, 2017 | -20,000.00 |
| Jun 30, 2017 | -2.79 Bn |
| Mar 31, 2017 | -24,000.00 |
| Dec 31, 2016 | -2.74 Bn |
| Sep 30, 2016 | -2.79 Bn |
| Jun 30, 2016 | -21,000.00 |
| Mar 31, 2016 | -19,000.00 |
| Dec 31, 2015 | -20,000.00 |
| Sep 30, 2015 | -19,000.00 |
| Jun 30, 2015 | -20,000.00 |
| Mar 31, 2015 | -2.53 Bn |
| Dec 31, 2014 | -2.49 Bn |
| Sep 30, 2014 | -11,000.00 |
| Jun 30, 2014 | 2.42 Bn |
| Mar 31, 2014 | 2.35 Bn |
| Dec 31, 2013 | -2.30 Bn |
| Sep 30, 2013 | -9,000.00 |
| Jun 30, 2013 | -8,000.00 |
| Mar 31, 2013 | 2.15 Bn |
| Dec 31, 2012 | -6,000.00 |
| Sep 30, 2012 | -8,000.00 |
| Jun 30, 2012 | -9,000.00 |
| Mar 31, 2012 | -3,000.00 |
| Dec 31, 2011 | 44,000.00 |
| Sep 30, 2011 | 45,000.00 |
| Jun 30, 2011 | 1.86 Bn |
| Dec 31, 2010 | 1.77 Bn |